Stockreport

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

ABLIVA AB  (NEVPF) 
NASDAQ:AMEX Investor Relations: neurovive.com/investor
PDF LUND, Sweden, July 27, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTA [Read more]